Grace Therapeutics, Inc. (GRCE) Max Pain Analysis

Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.

Grace Therapeutics, Inc. (GRCE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $34.8M, listed on NASDAQ, employing roughly 4 people, carrying a beta of 0.32 to the broader market. Grace Therapeutics, Inc. Led by Prashant Kohli, public since 2012-02-07.

Snapshot as of May 15, 2026.

Spot Price
$2.19
Total OI
20.7K

Learn how max pain is reported and how to read the data →